These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


207 related items for PubMed ID: 11110228

  • 1. Rosiglitazone in the treatment of type 2 diabetes mellitus: a critical review.
    Malinowski JM, Bolesta S.
    Clin Ther; 2000 Oct; 22(10):1151-68; discussion 1149-50. PubMed ID: 11110228
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Thiazolidinediones in type 2 diabetes mellitus: current clinical evidence.
    Diamant M, Heine RJ.
    Drugs; 2003 Oct; 63(13):1373-405. PubMed ID: 12825962
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A systematic review of the clinical effectiveness of pioglitazone in the treatment of type 2 diabetes mellitus.
    Chilcott J, Tappenden P, Jones ML, Wight JP.
    Clin Ther; 2001 Nov; 23(11):1792-823; discussion 1791. PubMed ID: 11768834
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Rosiglitazone: a review of its use in the management of type 2 diabetes mellitus.
    Wagstaff AJ, Goa KL.
    Drugs; 2002 Nov; 62(12):1805-37. PubMed ID: 12149047
    [Abstract] [Full Text] [Related]

  • 12. Rosiglitazone does not alter the pharmacokinetics of metformin.
    Di Cicco RA, Allen A, Carr A, Fowles S, Jorkasky DK, Freed MI.
    J Clin Pharmacol; 2000 Nov; 40(11):1280-5. PubMed ID: 11075314
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Pharmacokinetics and clinical efficacy of pioglitazone.
    Hanefeld M.
    Int J Clin Pract Suppl; 2001 Sep; (121):19-25. PubMed ID: 11594240
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Thiazolidinediones: a comparative review of approved uses.
    Sood V, Colleran K, Burge MR.
    Diabetes Technol Ther; 2000 Sep; 2(3):429-40. PubMed ID: 11467345
    [Abstract] [Full Text] [Related]

  • 19. Rosiglitazone : a review of its use in type 2 diabetes mellitus.
    Deeks ED, Keam SJ.
    Drugs; 2007 Sep; 67(18):2747-79. PubMed ID: 18062722
    [Abstract] [Full Text] [Related]

  • 20. Pioglitazone hydrochloride in combination with metformin in the treatment of type 2 diabetes mellitus: a randomized, placebo-controlled study. The Pioglitazone 027 Study Group.
    Einhorn D, Rendell M, Rosenzweig J, Egan JW, Mathisen AL, Schneider RL.
    Clin Ther; 2000 Dec; 22(12):1395-409. PubMed ID: 11192132
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.